Private Equity, VC & Investor · Advertiser / Brand · vs · Agency & Consultancy
Houlihan Lokey vs Melius Research
Structured technology and market comparison · 2026
Direct Feature Comparison
Houlihan Lokey · vs · Melius ResearchIndependent investment bank for M&A, restructuring and valuation advisory.
Independent equity research and analytics for institutional clients.
Analyze all overlapping signals and tech stacks for Houlihan Lokey and Melius Research
Compare mutual enterprise clients, monetization models, live market signals, and partner networks directly in the interactive Knowledge Graph.
Comparison Analysis
What is the main difference between Houlihan Lokey and Melius Research?
When comparing Houlihan Lokey and Melius Research, both platforms operate within the Other / Non-Digital Advertising Relevant ecosystem. Houlihan Lokey is positioned as Independent investment bank for M&A, restructuring and valuation advisory, whereas Melius Research focuses on Independent equity research and analytics for institutional clients. Decision-makers evaluate both solutions when orchestrating their commercial monetization and technology stack.
What are the top alternatives to Houlihan Lokey and Melius Research?
When evaluating Houlihan Lokey and Melius Research, enterprise buyers also consider other platforms in Other / Non-Digital Advertising Relevant. You can discover the full competitive landscape and evaluate other alternatives by viewing their respective footprint profiles on Polaris7.
How do the corporate scale, structure, and headquarters of Houlihan Lokey and Melius Research compare?
Houlihan Lokey is headquartered in US (founding year unrecorded) with 1,001–5,000 employees. Melius Research is based in US (founded in 2017) with 10–49 employees. Complete ownership, subsidiary trees, and corporate affiliations are documented across Polaris7.
Market Signals
Recent Market Signals & Activity: Houlihan Lokey vs Melius Research
Documented market movements, strategic partnerships, product releases, and regulatory developments mapped across Polaris7.
Houlihan Lokey
Recent Signals
- ·SEC APIfinancials
8-K Financial Filing Analysis for Houlihan Lokey (2026-09-22)
Houlihan Lokey reported several key governance and leadership actions following its annual stockholder meeting on September 16, 2026. Stockholders approved the Second Amended and Restated 2016 Incentive Award Plan, which sets the reserved share pool at 12 million shares, reinstates an annual evergreen replenishment at a reduced 1% rate (down from 6%), and eliminates the fixed plan expiration date. Additionally, the company announced the election of Thomas Reichert to the Board as an independent Class I director effective October 1, 2026, receiving a $120,000 initial restricted stock grant. In executive leadership changes, General Counsel Christopher M. Crain retired to transition into a Corporate Senior Advisor role, and Prabha Sipi Bhandari was appointed as Chief Legal Officer and Secretary.
- Stockholders approved the Second Amended and Restated 2016 Incentive Award Plan, establishing a 12 million share reserve and resetting annual evergreen dilution increases to 1% (down from 6%).
- Thomas Reichert was elected as an independent Class I director effective October 1, 2026, receiving a $120,000 restricted stock grant vesting over three years.
- Christopher M. Crain retired as General Counsel to become Corporate Senior Advisor, with Prabha Sipi Bhandari appointed as Chief Legal Officer and Secretary on September 16, 2026.
- ·DigidayM&A
Ad Tech's Public Market Woes: Investment Banker Explains Small-Cap Problem
At ExchangeWire's ATS London conference, investment banker Josh Wepman of Houlihan Lokey argued that the struggles of publicly-traded ad tech companies stem from their small market capitalizations, not performance. Most companies are too small to attract significant investment from index funds and mutual funds, with 'it's hard to be a $7 billion company' serving as a key quote. Deal activity has picked up to around $14 billion so far in 2026, but transactions are fewer and larger. Nick Macshane of Progress Partners noted extreme volatility in ad tech stocks, with some companies swinging 60% up or down, suggesting many should not be public. The article highlights take-private trends, mentioning Criteo's rumored buyout, and companies like DoubleVerify, LiveRamp, and Integral Ad Science moving off public markets. It also notes enterprise interest from Salesforce, Adobe, ServiceNow, Workday, Databricks, Snowflake, and OpenAI.
- Josh Wepman, MD at Houlihan Lokey, says public ad tech companies are too small for index/mutual funds to invest meaningfully.
- Public ad tech stocks have underperformed broader tech indices, with declining multiples through 2025-2026.
- Deal activity reached approximately $14 billion so far in 2026, spread across fewer, larger deals.
Melius Research
Recent Signals
- ·CNBC TechnologyEarnings Report
Apple's iPhone Duo Shows Strong Preorder Demand, Boosts Growth Outlook
Apple's first foldable device, the iPhone Duo, is showing extremely strong early demand following its preorder launch, validating Jim Cramer's bullish prediction. Morgan Stanley reports record global preorder lead times, with the earliest delivery dates for some models more than three months out, the longest in the last 10 years. This demand is seen as a key catalyst for Apple's growth, with Melius Research estimating over 15 million units could be sold in fiscal 2027, generating roughly $40 billion in revenue. The analyst notes that the strong Duo demand may also help iPhone 18 sales. Apple's stock has surpassed a $5 trillion market cap for the first time, and the company is expected to report earnings on November 2.
- Apple's iPhone Duo preorders started Friday, with strong demand indicated by long shipping delays.
- Morgan Stanley reported the global 14-week average preorder lead time is a record, the longest of any iPhone model in 10 years.
- Melius Research estimates Apple could sell at least 15 million Duo units in fiscal 2027, generating about $40 billion in revenue.
- ·CNBC InvestingFinancials
Intel could hit $200 per share in two years, says Melius analyst
Melius Research analyst Ben Reitzes has set a buy rating on Intel with a $165 price target, implying about 70% upside from the previous close, but sees the stock reaching as high as $200 per share within two years. Reitzes bases his bullish outlook on potential foundry agreements with Apple, Tesla, and another hyperscaler, and strong server CPU pricing and AI PC mix that could drive product earnings above $4. He also notes a Reuters report that Intel is considering a deal to help SK Hynix manufacture memory chips in the U.S., potentially leasing part of its Ohio facility. Intel shares have gained roughly 300% over the past 12 months, and the stock was up more than 4% on the day. The analyst's view contrasts with consensus, as only 15 of 50 analysts rate it a buy.
- Melius Research has a buy rating on Intel with a $165 price target, implying ~70% upside.
- Analyst Ben Reitzes sees Intel trading as high as $200 per share in the next two years.
- Intel could rally on foundry agreements with Apple, Tesla, and another hyperscaler, per analyst.
Compare their exact ecosystem overlaps.
Explore all deep relationships in Polaris7. Discover exactly which mutual clients, integrated technologies, and overlapping partners Houlihan Lokey and Melius Research share across the market ecosystem.
Unlock full capability matrix, client overlaps & technology stacks